Cancer Communications
indexed by SCI

About the cover
About the cover

Feb. 2015; Volume 34 Issue 2

February 27, 2004, Roche announced that Genentech has received approval from the US Food and Drug Administration (FDA) for Avastin (bevacizumab, rhuMAb-VEGF), an innovative new cancer drug, to be used with intravenous 5-Fluorouracil-based chemotherapy as treatment for patients with previously untreated metastatic cancer of the colon or rectum (first-line treatment).

Receptor-type protein tyrosine phosphatases in cancer
Yu Du, Jennifer R. Grandis
[ Abstract  2225]   [ PDF Full-text  2227]     [ HTML PMC ]  Page: 61-69  Epub: 2014-10-17  doi: 10.5732/cjc.014.10146
Original Article
Use of subsequent PET/CT in diffuse large B-cell lymphoma patients in complete remission following primary therapy
Xu Zhang, Wei Fan, Zhong-Jun Xia, Ying-Ying Hu, Xiao-Ping Lin, Ya-Rui Zhang, Zhi-Ming Li, Pei-Yan Liang, Yuan-Hua Li
[ Abstract  3231]   [ PDF Full-text  2633]     [ HTML PMC ]  Page: 70-78  Epub: 2014-11-21  doi: 10.5732/cjc.014.10124
Optimal follow-up duration for evaluating objective response to radiotherapy in patients with hepatocellular carcinoma: a retrospective study
Moonkyoo Kong, Seong Eon Hong
[ Abstract  2073]   [ PDF Full-text  1919]     [ HTML PMC ]  Page: 79-85  Epub: 2014-11-21  doi: 10.5732/cjc.014.10136
Survival analysis of children with stage II testicular malignant germ cell tumors treated with surgery or surgery combined with adjuvant chemotherapy
Su-Ying Lu, Xiao-Fei Sun, Zi-Jun Zhen, Zi-Ke Qin, Zhuo-Wei Liu, Jia Zhu, Juan Wang, Fei-Fei Sun
[ Abstract  2191]   [ PDF Full-text  2442]     [ HTML PMC ]  Page: 86-93  Epub: 2014-10-17  doi: 10.5732/cjc.014.10027
Case Research
Toxic epidermal necrolysis related to AP (pemetrexed plus cisplatin) and gefitinib combination therapy in a patient with metastatic non-small cell lung cancer
Ji-Jie Huang, Shu-Xiang Ma, Xue Hou, Zhao Wang, Yin-Duo Zeng, Tao Qin, Xiao-Xiao Dinglin, Li-Kun Chen
[ Abstract  2675]   [ PDF Full-text  2329]     [ HTML PMC ]  Page: 94-98  Epub: 2014-11-21  doi: 10.5732/cjc.014.10151

CC Wechat 微信公众号


Editorial Manager

CC adopts Editorial Manager to manage its submissions from Dec.18, 2014


Reference style for  

 Reference Manager

Editorial Manager





Advanced search


CJC is now published by BioMed Central

© Chinese Journal of Cancer

Sun Yat-sen University Cancer Center

651 Dongfeng Road East, Guangzhou 510060, P. R. China